UPDATE 2-Eli Lilly banks on cost controls for higher 2013 profit

Jan 4 (Reuters) - Pharmaceutical maker Eli Lilly and Co. said on Friday it expects to increase profits in 2013, primarily due to cost controls and productivity gains off of a much weaker 2012 when sa…

---

Otsuka Pharmaceutical Co., Ltd. and Lundbeck Inc. Initiate the Regulatory Process for Aripiprazole (Once-Monthly) Depot Formulation in Europe

TOKYO & COPENHAGEN, Denmark--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced the European Medicines Agency's (EMA) acceptance of the submis…

---

Takeda, Amylin terminate anti-obesity compound development deal

Takeda Pharmaceutical Company and Amylin Pharmaceuticals have mutually terminated their worldwide agreement signed in October 2009 to co-develop and commercialize anti-obesity compounds.

---

U.S. SEC says Eli Lilly to pay $29 mln to settle bribery charges

WASHINGTON, Dec 20 (Reuters) - Pharmaceutical company Eli Lilly and Co agreed on Thursday to pay $29 million to settle civil charges that its subsidiaries made improper payments to foreign government…

---